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http://dx.doi.org/10.1016/j.stemcr.2017.08.016SUMMARYHuman pluripotent stem cell (hPSC)-derivedmesencephalic dopaminergic (mesDA) neurons can relievemotor deficits in animalmodels
of Parkinson’s disease (PD). Clinical translation of differentiation protocols requires standardization of production procedures, and sur-
face-marker-based cell sorting is considered instrumental for reproducible generation of defined cell products. Here, we demonstrate that
integrin-associated protein (IAP) is a cell surface marker suitable for enrichment of hPSC-derived mesDA progenitor cells. Immunomag-
netically sorted IAP+ mesDA progenitors showed increased expression of ventral midbrain floor plate markers, lacked expression of
pluripotencymarkers, and differentiated intomature dopaminergic (DA) neurons in vitro. Intrastriatal transplantation of IAP+ cells sorted
at day 16 of differentiation in a rat model of PD resulted in functional recovery. Grafts from sorted IAP+ mesDA progenitors were more
homogeneous in size and DA neuron density. Thus, we suggest IAP-based sorting for reproducible prospective enrichment of mesDA
progenitor cells in clinical cell replacement strategies.INTRODUCTION
Parkinson’s disease (PD) is a common neurodegenerative
disorder primarily involving degeneration of dopaminergic
(DA) neurons in the substantia nigra (SN). DA neurons
located in the SN project to the striatumwhere they release
dopamine and have a crucial role in motor control. Pre-
clinical studies, as well as clinical trials, have shown that
transplantation of fetal mesencephalic tissue can restore
dopaminergic activity and reduce motor symptoms in PD
patients for up to 18 years (Barker et al., 2013, 2015; Kefa-
lopoulou et al., 2014). Recent studies in animal models of
PD suggest that DA progenitors differentiated from human
pluripotent stem cells (hPSCs) constitute an alternative cell
source for transplantation therapy, showing a similar ca-
pacity to fetal tissue in terms of ability for terminal differen-
tiation capacity for integration and projection, regulated
dopamine release, and functional recovery of Parkinsonian
symptoms (Doi et al., 2014; Grealish et al., 2014; Kirkeby
et al., 2012a; Kriks et al., 2011; Steinbeck et al., 2015).
Therefore, transplantation of hPSC-derived mesDA neu-
rons may constitute a promising future therapy for PD
patients, suitable for the treatment of large cohorts.
While hPSC differentiation protocols have improved in
terms of quality and reproducibility over the past years,
it is a common observation that hPSC-derived differentia-
tion cultures still represent heterogeneous mixtures of
cells, containing a variety of phenotypes and degrees ofStem Cell Reports j Vol. 9
This is an open access article under the Cmaturity. Furthermore, resulting cell compositions vary
between experiments and cell lines (Osafune et al., 2008).
Also, the safety aspect is of paramount importance since
remaining undifferentiated hPSCs pose a risk of teratoma
formation after transplantation (Brederlau et al., 2006;
Doi et al., 2012; Sonntag et al., 2007), and poorly differen-
tiated cells with high proliferative capacity have been asso-
ciated with neural tissue overgrowth in vivo (Lindvall and
Kokaia, 2009). In addition, contaminating serotonergic
neurons have been discussed as a possible contributing fac-
tor to graft-induced dyskinesia (Carlsson et al., 2007; Politis
et al., 2010). Cell sorting is considered to be instrumental
for reproducible generation of safe and defined functional
cell products (Bye et al., 2015; Ganat et al., 2012; Tabar
and Studer, 2014; Villaescusa and Arenas, 2010). Magnetic
cell sorting has been reported to allow faster and gentler
handling of cells (Bosio et al., 2009; Pruszak et al., 2007),
stable engraftment, and survival of transplanted embry-
onic stem cell (ESC)-derived neural cells (Barral et al.,
2013; Bryson et al., 2014). Importantly, magnetic cell sort-
ing can be utilized in large-scale clinical procedures under
sterile conditions (Despres et al., 2000; Schumm et al.,
2013).
Previous rodent studies have identified CORIN, PSA-
NCAM, and ALCAM (Bye et al., 2015; Friling et al.,
2009; Ono et al., 2007) as mesDA progenitor-associated
cell surface markers. Antibodies directed against CORIN,
NCAM, and LRTM1 were also used to enrich hPSC-derivedj 1207–1220 j October 10, 2017 j ª 2017 Miltenyi Biotec GmbH. 1207
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
dopaminergic neurons that could ameliorate motor symp-
toms in animal models of PD. However, in these studies,
cells were either cultivated for an extended time between
sorting (day 12) and transplantation (day 28/42) (Doi
et al., 2014; Hargus et al., 2010; Samata et al., 2016) or
were sorted and transplanted as late as day 42 (d42) of dif-
ferentiation and in this case resulted in poor graft survival
(Hargus et al., 2010).
No systematic marker identification studies have been
reported for human mesDA cells. We screened a library of
312 annotated antibodies and discovered integrin-associ-
ated protein (IAP, CD47) as a cell surface marker suitable
for immunomagnetic isolation of FOXA2+ hPSC-derived
mesDA progenitor cells with floor plate identity. IAP-based
cell sorting may therefore contribute to the generation of
more homogeneous cell products for future clinical use.RESULTS
Identification of IAP as a Cell Surface Marker for
mesDA Progenitor Cells
To identify a surface marker suitable for cell sorting, we
performed a flow cytometry-based surface marker screen
on hPSC-derived mesDA progenitor cells, generated based
on the protocol developed by Kirkeby et al. (2012a) with
minor modifications (Figure 1A).
We used two hPSC lines, one of embryonic origin (H9)
and one hiPSC line originally derived fromhuman foreskin
fibroblasts (hFF-iPSC). Measurements were performed on
d11 and d16 of differentiation to cover early as well as
morematuremesDA progenitors. SincemesDA progenitors
from both stages expressed FOXA2+/LMX1A+, we used
FOXA2 counterstaining to identify the cells of interest
and their correlation to a total of 312 surface markers. We
identified 29 markers strongly expressed on the FOXA2+
cells (>90% positive cells) in any of the cell lines or time
points. Twelve of these surface markers were concomi-
tantly expressed on d11 and d16 of differentiation in
both H9 and hiPSC-derived FOXA2+ cells (Figure 1B, Table
S5). The surface marker IAP emerged as a suitable marker
for cell sorting with superior discrimination between the
FOXA2+ target cells and FOXA2 non-target cells over all
other markers tested (Figure 1C). The robust correlation
of IAP and FOXA2 expression observed by flow cytometry
analysis (Figures 1D and S1) could also be confirmed using
immunofluorescence microscopy (Figure 1E) and using
two more cell lines (hESC: SA001, hiPSC: hCBEC-iPSC;
data not shown).
In order to characterize the IAP+ cells more closely,
further co-staining with known surface as well as intracel-
lular markers were performed on hiPSC and hESC-derived
mesDA progenitors on d11 and d16 and analyzed by flow1208 Stem Cell Reports j Vol. 9 j 1207–1220 j October 10, 2017cytometry (Figures 2A, 2B, and S2) Expression of the plurip-
otencymarker OCT4was negligible in both cell lines at d11
and d16. Likewise, SOX1 a primitive neuroectodermal
marker later restricted to the lateral floor plate (Wood and
Episkopou, 1999) was not expressed at these time points.
SOX2 expression was slightly elevated in IAP+ cells and
decreased from d11 to d16. Expression of Ki67 diminished
from nearly 100% in the pluripotent state (not shown) to
60%–40% at d11 and 50%–10% at d16, with the hESCs
showing a faster drop in proliferation marker expression
over time, as observed for SOX2. Absence of NKX2.1
confined to the forebrain and PAX6 expressed in the roof
plate (Kirkeby et al., 2017) of the neural tube indicated
that cells were patterned to a ventralized fate rostral of
the midbrain hindbrain boundary. NCAM was broadly ex-
pressed on IAP and IAP+ cells at d11. At d16, 85% of the
hiPSC-derived and 98% of the hESC-derived IAP+ cells ex-
pressed NCAM. However, the IAP fractions contained
17% and 66% NCAM+ cells, respectively, indicating that
IAP+ cells represent a subpopulation of NCAM+ cells.
A comparable expression pattern was observed for PSA-
NCAM. In contrast, CORIN expression was restricted to
the IAP+ cells already at d11. At d16, CORIN correlated
nearly completely in the hESC-derived cells while only
a subpopulation of the hiPSC-derived IAP+ cells showed
co-expression with CORIN, indicating that the CORIN
fraction represents a subpopulation of the IAP+ fraction.
Since IAP is widely expressed in mesoderm-derived tissues,
we analyzed the co-expression of IAP and prototypic
mesodermal markers under the described differentiation
conditions. The tested markers representing blood, endo-
thelial, mesenchymal stromal, and epithelial cells were
either not detected or negatively correlated (Figure S2).
Next, we analyzed the in vivo expression pattern of IAP in
the developing neural tube of the human embryo. The neu-
ral tube can be subdivided in four domains along the ven-
tro-dorsal axis: floor plate, basal plate, alar plate, and roof
plate (Shimamura et al., 1995; Verney et al., 2001). Immu-
nofluorescence analyses were performed on coronal sec-
tions of the ventral midbrain (VM) area of human embryos
7 weeks post conception (p.c.) (Figure 2B). As seen for their
counterparts generated in vitro, IAPwas indeed expressed in
the FOXA2+/LMX1A+ floor plate cells predominantly in the
midline and the mantle zone (Figure 2C). In addition, we
detected IAP expression in the roof plate where it co-local-
ized with LMX1A but not FOXA2. To translate and better
understand the spatial distribution of IAP expression in
the context of neural differentiation of hPSC, wemimicked
the neural tube domains by patterning differentiating cells
along the ventro-dorsal axis (Kirkeby et al., 2012b). As pre-
dicted, IAP showed a distinct co-expression with FOXA2 in
the ventralized floor plate cells. Under basal plate induc-
tion conditions, FOXA2+ cells expressed IAP to a certain
Figure 1. Identification of IAP as a Cell Surface Marker Expressed in FOXA2+ mesDA Progenitor Cells
(A) mesDA were differentiated according to the protocol of Kirkeby et al. (2012a). Cells were harvested for a flow-cytometry-based surface
marker screening on d11 and d16. AA, ascorbic acid; FN, fibronectin; lam, laminin; MN, MACS Neuro medium; NB-21, NeuroBrew-21; PO,
poly-L-ornithine.
(B) hESCs (H9) and hiPSCs (hFF-iPS) were differentiated toward mesDA progenitor cells and screened for marker expression on d11 and d16
of differentiation. Surface markers expressed on >90% of the FOXA2+ mesDA progenitor cells are depicted in the Edwards-Venn diagram
(Bardou et al., 2014); see also Table S5. Twelve surface markers were concomitantly expressed on d11 and d16 in both hESC and hiPSC-
derived FOXA2+ cells.
(C) Comparative analysis of the 12 surface markers expressed in hESCs and hiPSCs at d11 and d16 of differentiation. Shown is the ratio of
the mean fluorescence intensity (MFI) for each marker for FOXA2+ and FOXA2 cells. IAP displayed the highest discrimination between
FOXA2+ and FOXA2 cells on hiPSCs and hESCs at d11 and d16.
(D) Schematic illustration of the gating strategy used for the cell surface marker screening. Single cells were distinguished by the FSC
properties, and cells of interest were gated based on FSC/SSC characteristics. As shown for IAP, surface markers expressed by mesDA
progenitors were identified based on the co-staining with FOXA2. See also Figure S1.
(E) Immunofluorescence staining of mesDA progenitor cells on d11 showed co-expression of IAP (red) and FOXA2 (green); Cell nuclei were
stained with DAPI (blue). Scale bar represents 100 mm.
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Figure 2. Characterization of IAP Expres-
sion In Vitro and In Vivo
(A and B) Flow cytometric analysis of IAP
positive and negative cells on (A) d11 or
(B) d16 of differentiation with respect to
expression of known markers for pluripo-
tent, neural (stem) cells. Bar graph shows
the frequency of each marker expressed by
the IAP+ and IAP subsets for differentiated
hESCs and hiPSCs as the mean of inde-
pendent triplicates (mean ± SD). See also
Figure S2.
(C) Protein expression in the neural tube
of the human fetal mesencephalon (7 weeks
p.c.). FOXA2 (red) is expressed within the
floor plate and basal plate, LMX1A (blue)
delineates the floor plate and the roof plate
in human VM. IAP (green) expression was
observed in the floor plate as well as in the
roof plate. Cell nuclei stained with DAPI are
shown in white. Scale bar represents 500 mm
in the overview and 50 mm in close up.
(D) hiPSCs were differentiated toward floor
plate, basal plate, alar plate, and roof plate
fates, respectively. Color code indicates
floor plate (black), basal plate (gray), alar
plate (blue), and roof plate (white). Cells
differentiated for 11 days in vitro were
analyzed for IAP and FOXA2 expression us-
ing flow cytometry. Bar graphs illustrate the
frequency (%) of FOXA2+ cells in the IAP+
fraction (n = 3; independent experiments;
mean ± SD). Representative density plots
are depicted for each differentiation con-
dition.frequency, but the expression level was much lower
compared with floor plate patterned cells. In the alar and
roof plate regimens, lower numbers of IAP-expressing cells
and a lower expression level of IAP were detected (Fig-
ure 2D). In summary, IAP is suited for enrichment of
hPSC-derived mesDA progenitors from ventrally patterned
cells.1210 Stem Cell Reports j Vol. 9 j 1207–1220 j October 10, 2017Immunomagnetic Sorting of IAP+ Cells Allows for the
Isolation of mesDA Progenitor Cells
Consequently, we established a sorting strategy for the
enrichment of mesDA progenitor cells based on immuno-
magnetic isolation of IAP+ cells (Figure 3A). Flow cytometric
analyses of differentiatedmesDAprogenitor cells showed an
initial frequency of IAP+ cells of 49% ± 18.99% (n = 20) on
Figure 3. Purification and Characterization of IAP+ mesDA Progenitor Cells
(A) The frequency of IAP+ (d11) in the unsorted fraction accounted for 53% (left blot). After the immunomagnetic sorting, IAP+ cells were
enriched to a purity of 98%.
(B) Sorting efficiencies of IAP+ cells derived from d11 and d16 of differentiation measured by flow cytometry. Gray symbols indicate
differentiated hESCs and black symbols represent differentiated hiPSCs (d11 n = 20; d16 n = 7; independent experiments; mean ± SD;
***p < 0.005 according to Student’s t test).
(C) Immunofluorescence analysis of the unsorted and IAP+ cell fraction. LMX1A (green) and FOXA2 (red). LMX1A+/FOXA2+ cells are shown
in the merged picture. In contrast to the unsorted cells, the IAP+ cells reveal homogeneous FOXA2/LMX1A co-expression 3 days after
replating. Scale bar represents 100 mm.
(D) Gene expression analysis for FOXA2, LMX1A, and CORIN on the unsorted, IAP, and IAP+ cells by qRT-PCR. Values are shown as the
relative expression of each gene compared with the unsorted fraction (n = 3; independent experiments; mean ± SD; *p < 0.05; **p < 0.005;
according to Student’s t test).
(E) IAP+ versus IAP cells sorted on d16 of differentiated hESCs and hiPSCs. The color represents log2 intensity values centered to the
gene-wise median of all samples; saturation limits are indicated in the green-black-red color bar above the heatmap. The sample groups are
(legend continued on next page)
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d11 and 62.30% ± 8.87% (n = 7) on d16, independent of the
source of cells used, i.e., hiPSCs or hESCs. Immunomagnetic
cell sorting enriched IAP+ cells to92.04%±6.87%(n=20) on
d11 and to 93.08% ± 2.94% (n = 7) on d16 of differentiation
(Figure 3B). The viability of the IAP+ cells was not affected by
immunomagnetic sorting (99.37% ± 0.56%; n = 10) based
on flow cytometric analyses. Therefore, IAP-based sorting
results were highly consistent, independent of the starting
frequency of IAP+ cells or day of differentiation.
Sorted and unsorted cells were replated at d11 and
further analyzed at d14 to elucidate FOXA2+/LMX1A+ co-
expression using immunofluorescence. The IAP+ cell popu-
lation had a higher expression of FOXA2 and LMX1A
compared with the unsorted cells (Figure 3C). qRT-PCR re-
vealed that the expression levels of mesencephalic floor
plate markers LMX1A and FOXA2were significantly higher
in the IAP+ cells compared with the unsorted fraction (Fig-
ure 3D), as well as the surface mesDA marker CORIN.
To further delineate the differences between the un-
sorted, IAP+, and IAP cells, we analyzed the gene expres-
sion profiles using a human whole-genome array. mesDA
progenitor cells were sorted on d16 of differentiation
(hiPSC and H9 hESC). The frequency of IAP+ cells within
the unsorted samples on d16 was 70.9% ± 0.9% (n = 3) for
hiPSC and 58.2% ± 1.7% (n = 3) for hESC-derived mesDA
progenitors. After sorting, only a small percentage of IAP+
cells were retained in the negative fraction (5.9% ± 0.1%
and 1.8% ± 1.2% respectively), while the corresponding
IAP+ cell fraction was enriched to 93.8% ± 0.1% and
90.7% ± 1.9%. Since the enrichment factor was 1.3 and
1.5 for hiPSCs and hESCs, respectively, we expected only
minor differences between the unsorted and IAP+ fraction
using global expression analyses. Therefore, we focused
on comparative analysis of the IAP+ and IAP fractions in
order to characterize the IAP+ cells further.
Pathway analysis of the significant differentially ex-
pressed genes between the d16 IAP+ and IAP fractions
showed regulation of pathways involved in midbrain
development, specifically Smoothened, BMP, and WNT
pathways (Figures 3E and S3). Furthermore, regulation of
genes associated with Integrin and death receptor pathway
could be detected. The respective up- or downregulation of
key genes of these pathways resembled the stronger
response and adaptation of the IAP+ cells to the patterning
cues of the differentiation process.
Mesencephalic-specific genes and mesDA progenitor-
associated genes such as FOXA2, FOXA1, LMX1A, LMX1B,depicted by orange/yellow color bars above the heatmap. Shown is
candidate genes (see color bars on the right-hand side of the heatma
(F) Gene expression trends of hESC-derived mesDA progenitors d16 un
unfiltered normalized log2 intensities of IAP versus IAP+ cells are c
normalized log2 intensities of independent experiments of the unsor
1212 Stem Cell Reports j Vol. 9 j 1207–1220 j October 10, 2017RFX4, SLIT2, CNPY1 (Kirkeby et al., 2017; La Manno et al.,
2016), and CORIN were higher expressed in the IAP+ cells
compared with the IAP cells (Figure 3F). Furthermore,
non-neural genes, such as DLK1, genes associated with
non-VM neural fates (e.g., DECORIN, PAX6, SIX3), and
genes associated with pluripotency, such as POU5F1 and
NANOG were either expressed at a low level after 16 days
of in vitro differentiation or, if detected, showed higher
expression in the IAP fraction (Figure 3F).
The potential of the sorted cells to develop into dopami-
nergic neurons was assessed by replating the unsorted,
IAP+, and IAP fractions after sorting on d16 and subse-
quent terminal differentiation in vitro until d50. Immuno-
fluorescence analyses for the neural marker TUJ1 and the
dopamine neuron marker TH showed a high level of co-
expression (Figure 4A). qRT-PCR analyses revealed that
mesencephalic genes such as LMX1A and LMX1B were
expressed to the same extent in the unsorted fraction as
in the IAP+ fraction, while higher expression of FOXA2
was observed in the IAP+ fraction, implying a mesDA
phenotype. EN1, TH, and SYP-1 were expressed in the
IAP fraction to a significantly higher extent compared
with the unsorted fraction. Interestingly, we observed
lower serotonergic gene expression, TPH2 and SERT, in
the IAP+ fraction compared with the IAP fraction (Figures
4B and S4).
Further pathway analyses of the differentially expressed
genes between the IAP+ cells at d16 of differentiation and
d16 sorted and terminally differentiated IAP+ cells until
d50 clearly showed associations of the upregulated genes
with dopamine, neuropeptide, and glutamate signaling
pathways in the terminally differentiated fraction (Fig-
ure 4C). As expected, genes for mature neurons were upre-
gulated in the terminally differentiated cells (BDNF, TH,
KCNJ6). Also genes associated with neurite outgrowth
such as Osteoglycin (OGN) and dopamine receptor genes
(DRD2, DRD4) were detected in the d50 cell fraction. In
contrast, expression of genes associated with early mesDA
progenitors was higher in the cells sorted and harvested
on d16 (FOXA2, OTX1, HES5) (Figure 4D).
The phenotype of DA neurons derived from IAP+ cells
was additionally assessed by comparing expression trends
between IAP+ cells at d16 and d50 cells derived thereof
with the expression difference of human embryonic neural
stem cells (NSCs) and in vivo tissue samples from mature
human DA neurons (Marei et al., 2011). For this, the
expression values of IAP+ d16 samples were plotted againsta selection of significantly enriched pathways associated with the
p). See also Figure S3.
sorted, IAP+, and IAP samples are summarized in scatterplots. The
ompared. The color code corresponds to the median values of the
ted fraction.
Figure 4. Gene Expression and Pathway Analysis of d16 Sorted IAP/+ Fractions and d16 IAP+ Cells Terminally Differentiated
until d50
(A) Immunofluorescence staining of differentiated hESCs, positively sorted for IAP on d16 and replated for terminal differentiation until
d50. Mature dopaminergic neurons are detected by TH (green) and TUJ1 (red) co-staining (shown as merged picture). Cell nuclei were
stained with DAPI (blue). Scale bar represents 100 mm.
(B) Gene expression analysis (qRT-PCR) of differentiated hESCs at d50. Sorting was performed at d16 of differentiation of hESCs, and
unsorted, IAP, IAP+ cell fractions were replated for terminal differentiation. Shown is the mRNA expression of selected genes within the
IAP+ and the IAP fractions relative to the expression of the unsorted fraction (n = 3; independent experiments; mean ± SD; *p < 0.05;
**p < 0.005; ***p < 0.0005). See also Figure S4.
(C) IAP+ cells sorted on d16 versus IAP+ cells sorted on d16 and subsequently differentiated until d50. The color represents log2 intensity
values centered to the gene-wise median of all samples; saturation limits are indicated in the green-black-red color bar above the heatmap.
The sample groups are depicted by blue color bars above the heatmaps. Shown is a selection of significantly enriched pathways associated
with the candidate genes (see color bars on the right-hand side of the heatmaps).
(D) The d16 sorted IAP+ sample set versus IAP+ cells sorted on d16 and subsequently differentiated until d50. The color code corresponds to
the log2-fold change values of adult human dopaminergic neurons relative to human embryonic NSCs (GEO: GSE25931) (Marei et al., 2011).
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those of the d50 samples, and color coded by the fold-
change difference between mature human DA neurons
and human embryonic NSCs (Figure 4D). The majority of
genes with higher expression after 50 days of culture
compared with IAP+ cells isolated on d16 also showed
higher expression in vivo in DA neurons of adult human
brains than in human embryonic NSCs.
From these data, we concluded that sorting of IAP+ cells
led to a cell population highly enriched for mesDA progen-
itors and, at the same time, purged of cells with undesirable
phenotypes, such as serotonergic progenitors. Further-
more, the in vitro differentiation study of sorted mesDA
progenitor cells confirmed their capability to differentiate
into mature cells with phenotypic characteristics of dopa-
minergic neurons.
IAP+-Enriched Dopaminergic Progenitor Cells Survive
In Vivo and Differentiate to Mature Dopaminergic
Neurons
To assess the in vivo performance of IAP-sorted cells, un-
sorted cells and IAP+ cells from differentiated hiPSCs were
grafted intrastriatally into 6-OHDA-lesioned adult rats
kept under cyclosporin-mediated immunosuppression for
the duration of the experiment. We compared different
time points of sorting and transplantation to determine
the best regimen for transplantation in a 6-week survival
experiment (Figure 5A). One approach was to harvest
mesDA progenitor cells on d11 and transplant the immu-
nomagnetically sorted and unsorted cells. In a second set,
cells immunomagnetically sorted on d11 were replated
for transplantation on d16. Lastly, cells were immunomag-
netically sorted on d16, and sorted as well as unsorted cells
were transplanted immediately. All grafts were analyzed
6 weeks after transplantation. For the cells transplanted
on d11, we could not detect surviving cells regardless of
whether they were sorted or unsorted. All other conditions
transplanted on d16 resulted in neuron-rich grafts as deter-
mined by staining for human-specific NCAM (hNCAM)
(Figures 5B–5D). Grafts of the sorted cells were smaller
and had a more uniform graft size (Figure 5I). All animals
with surviving grafts contained TH+ neuron-rich grafts (Fig-
ures 5E–5G). Notably, while the TH count per graft was
lower for the sorted conditions, the TH density was higher.
Cells sorted and transplanted at d16 showed the highest
TH cell density and displayed themostmaturemorphology
(Figures 5H–5J).
In order to assess the full potential of the IAP+ popula-
tion, we performed long-term experiments to address if
the resulting grafts were functional in a rat model of PD.
For this purpose, hESCs (H9) were differentiated to a VM
fate, thereby focusing on the preferential transplantation
regimen identified in the survival study, i.e., the IAP+ pop-
ulation was sorted and grafted after 16 days (Figure 6A).1214 Stem Cell Reports j Vol. 9 j 1207–1220 j October 10, 2017Eighteen weeks post transplantation hNCAM-rich grafts
were observed in both the unsorted (Figure 6B) and IAP-
sorted groups (Figure 6D). Both groups generated grafts
dense with TH+ neurons (Figures 6C and 6E). Grafts from
sorted cells displayed a higher density of TH+ neurons (Fig-
ure 6F) than those from unsorted cells, while the general
cell density was comparable (Figure S5A). TH neurons
were clearly biased toward a GIRK2+ over a CALB+ pheno-
type (Figures 6G and S5B), the ratio being comparable in
both groups. However, grafts from IAP+ cells contained
significantly less serotonergic neurons (Figure 6H) and
slightly fewer proliferative cells than grafts from unsorted
cells (Figure S5C).
The functionality of the TH+ neurons was assessed using
amphetamine-induced rotation. Both groups demon-
strated complete functionality without lateral rotational
bias after 18 weeks (Figure 6I, n = 3 per group). Importantly,
the grafts from the sorted cells were smaller than their
counterparts from unsorted cells, and contained a modest
total number of TH+ neurons (5,200, 3,900, 840). This
showed that IAP-sorted cells can function near equipo-
tency of human fetal cells (Rath et al., 2013), as was also
previously demonstrated using unsorted hESC-derived
DA neurons (Grealish et al., 2014; Kirkeby et al., 2012a).
In summary, this dataset demonstrates that d16-sorted
IAP+ mesDA progenitors survive and mature long term
and provide functional recovery in a rodent model of PD.DISCUSSION
Our unbiased screening of 312 annotated antibodies led to
the identification of 12 candidate markers expressed pre-
dominantly on FOXA2+ cells at d11 and d16 of differentia-
tion, both for hESC and hiPSC-derived mesDA progenitor
cells. An antibody against IAP (CD47) allowed the most
reliable discrimination of FOXA2+ and FOXA2 cells and
thereby enabled prospective isolation ofmesDA progenitor
cells. IAP is a five-spanmembrane protein and amember of
the immunoglobulin superfamily. Most likely it has tissue-
specific isoforms and associates with integrins (Reinhold
et al., 1995). In mice, IAP is widely expressed in the brain,
especially in synapse-rich regions, and several functions
have been attributed to IAP in the developing mouse brain
(Huang et al., 1998; Jiang et al., 1999; Mi et al., 2000; Oh-
nishi et al., 2005). However, little is known about the
expression specificity of IAP in the developing human
brain. In particular, the specific role of IAP in hPSC-derived
dopaminergic progenitor cells remains to be elucidated.
Screening against FOXA2 allowed us to initially identify
markers associatedwith ventralized fates. Parallel screening
for LMX1Apositivitywas simply impeded by the lack of an-
tibodies suitable for flow cytometry. Therefore, regional
Figure 5. Six Week Survival of Unsorted
versus IAP+ hiPSC-DerivedmesDA Progen-
itors Grafted to the Striatum
Schematic experimental setup (A) and
histological analysis of grafts (B–G)
6 weeks after intrastriatal transplantation.
Cells were either transplanted on d11 (no
grafts detected) or d16 immediately after
IAP-based immunomagnetic enrichment
(D and G) or sorted on d11, replated and
transplanted at d16 (C and F), or trans-
planted on d16 without sorting (B and E).
Immunohistochemistry for hNCAM (B–D)
and TH (E–G) revealed that sorted cells gave
rise to smaller grafts (I) with overall lower
TH cell (H) count but higher TH density (J).
Transplanted animals: unsorted, n = 4; sor-
ted d11 tpl d16, n = 4; sorted d16, n = 5;
mean ± SD; *p < 0.05 according to one-way
ANOVA followed by Bonferroni post hoc test;
using IBM SPPS Statistics. Scale bar repre-
sents 500 mm in (B–G) and 50 mm in close-
up box (E–G). tpl, transplantation.identity, i.e., co-expression of FOXA2 and LMX1A, had to
be ensured by independent microscopic immunofluores-
cent analysis. We could validate that, under given differen-
tiation conditions, the surrogate marker FOXA2 would atthe same time be indicative ofmesDA progenitors with cor-
rect rostro-caudal patterning (Kirkeby et al., 2012a; Kriks
et al., 2011). Analyzing sections of the human fetal mesen-
cephalon (7 weeks p.c.) revealed that some IAP expressionStem Cell Reports j Vol. 9 j 1207–1220 j October 10, 2017 1215
Figure 6. Functional Potency Assessment of Unsorted versus IAP+ hESC-Derived mesDA Progenitors Grafted to the Striatum
Schematic experimental setup (A) and histological analysis of grafts (hNCAM: B, D; TH: C, E) 18 weeks after intrastriatal transplantation.
Transplantation of immunomagnetically enriched d16 IAP+ mesDA progenitors yielded grafts with higher TH density than from unsorted
control cells (F), see also Figure S5. Proportion of TH+ neurons coexpressing GIRK2 and Calbindin was comparable (G) the number of 5-HT+
cells was lower in grafts form IAP+ cells (H). IAP+ progenitors like the controls led to complete functional recovery in an amphetamine-
induced rotation assay 18 weeks after grafting (I). Transplanted animals: unsorted, n = 3; sorted, n = 3; mean ± SD. Scale bar represents
500 mm in (B–E) and 50 mm in close-up box (C and E).
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was detectable in the roof plate and themidline of the floor
plate region. Consequently, a weak expression of IAP could
also be detected in vitrowhen cells were deliberately dorsal-
ized. Upon ventralizing differentiation conditions, IAP reli-
ably identified FOXA2+/LMX1A+ mesDA progenitors. This
observation underlines the importance of using high-qual-
ity raw material and standardized protocols to ensure
properpatterningbut also independentquality control pro-
cedures for phenotyping of the resulting cell product.
Comparative flow cytometry characterization of the IAP+
and IAP fraction on the protein level at d11 andd16 aswell
as gene expression analysis on d16 of differentiation re-
vealed that IAP-basedsorting led toenrichmentof a cellpop-
ulation with correctly specified floor plate cells, as indicated
by a higher expression of specific markers such as LMX1A,
LMX1B, and FOXA2. IAP+ cells had established a FOXA2
expression circuitry as indicated by upregulation of the
FOXA2 target genes SHH, FOXA1, FERD3L (NATO3), and
SLIT2 and repression of SHH signaling pathway compo-
nents suchasPATCHED-1and -2,GLI-1and -2 (Metzakopian
et al., 2012), remarkably, 7 days after ventralizing factors
SHHandpurmorphaminehadbeen removed fromtheculti-
vation media. However, this transient cell state seems to be
dependent on further signaling to exert the full DA neuron
differentiation potential, as under the subsequent neuronal
differentiation conditions d16 IAP+ cells did not yield more
TH neurons than unsorted cells or even IAP cells in vitro.
Reasons for the latter observation could be the asynchrony
of differentiation cultures, as well as the limited ability to
mimic the rigorous developmental fate instruction in vitro.
Similarly, Aguila et al. (2014) failed to enrich dopami-
nergic neurons in subsequent differentiation after sorting
neuronal progenitors based on FOXA2-promoter driven
GFP-expression. Nonetheless, our cells sorted for IAP at
d16 and in vitrodifferentiated to d50 expressed genes related
tomaturedopaminergicneurons (TH,DRD2,DAT). Further-
more, these cells displayed lower relative gene expression
of serotonergic specific genes (TPH-2, SERT) in vitro, which
suggests a qualitative advantage connected to the IAP-
based progenitor selection. However, further studies need
to address this in more detail since the temporal aspects
as well as downstream differentiation conditions could
have a major impact on the final differentiation outcome.
Notably, in mouse floor plate cells, SHH expression was
shown to inhibit neuronal differentiation, andWNT/b-cat-
enin signaling is necessary and sufficient for antagonizing
SHH, DA progenitor marker induction, and promotion of
dopaminergic neurogenesis (Joksimovic et al., 2009). These
findings might add to further refinement of DA neuron ter-
minal differentiation in vitro.
More importantly, our in vivo study revealed the value of
IAP-based selection. We were able to demonstrate that in-
trastriatal transplantation of sorted hESC-derived IAP+ cellscould revert the motor symptoms in 6-OHDA-lesioned
rats and resulted in mature grafts after 18 weeks without
compromising cell survival, maturation, innervation, or
function. Beyond that, grafts from IAP+ cells contained
less 5-HT+ serotonergic neurons than grafts from unsorted
cells, which by itself is a very desirable feature since seroto-
nergic neurons are deemed to cause graft-induced dyski-
nesia. In contrast to previous studies, target cells could be
selected after only 16 days of differentiation and immedi-
ately transplanted without the need for prolonged in vitro
manipulation as reported for other protocols (Doi et al.,
2012; Hargus et al., 2010; Samata et al., 2016). IAP+ cells
gave rise to functional grafts without signs of overgrowth
or teratoma formation, thereby addressing the concern
related to hPSC-derived cell products. Grafts from sorted
cells had a higher TH density (i.e., TH+ cells/mm3) but
were smaller and contained fewer TH cells and less prolifer-
ative cells than the control grafts. This might be caused by
cells with a higher proliferative potential in the IAP frac-
tion within these grafts. This compares well with the obser-
vations in vitro indicating that some cells with epithelial
character (CD324 and CD326 positive cells) could be
observed in IAP-negative fractions at d16 of differentiation.
Vice versa this would imply that IAP+ cells tend to mature
faster into postmitotic cells in vivo. Finally, the increased
homogeneity of transplant size and function observed in
grafts obtained from the sorted cell fraction should increase
the predictability of graft size and thus facilitate dosing.
Notably, the occurrence of teratomas or neural over-
growths has not been a matter of concern for well-differen-
tiating hESCs such as H9 when applying new-generation
floorplate inductionprotocols (Grealish et al., 2014;Kirkeby
et al., 2012a;Kriks et al., 2011).However, other cell linesmay
exhibit less favorable risk profiles. Although differentiation
efficiencies have been constantly optimized (Kirkeby et al.,
2017), cell-line-specific variations cannot be excluded.
Therefore, cell sorting could increase the safety and func-
tionality of grafts from a broader range of cell sources.
From a translational perspective, our study clearly em-
phasizes the utility for IAP-based cell sorting of heteroge-
neous cell populations in order to meet safety and quality
requirements for future therapeutic cell products.EXPERIMENTAL PROCEDURES
Human Fetal Tissue
Human fetal tissue was obtained from legally terminated embryos
with approval of the SwedishNational Board ofHealth andWelfare
in accordance with existing guidelines, including informed con-
sent from women seeking elective abortions. The gestational age
of each embryo was determined by measuring the crown-to-
rump length and/or estimated by ultrasound measurements.
Embryos were then staged according to weeks post conception.Stem Cell Reports j Vol. 9 j 1207–1220 j October 10, 2017 1217
Human iPSC and ESC Culture
hFF-iPSCs were maintained on gamma-irradiated CF1-MEFs in
DMEM/F12 (Gibco) supplemented with 20% KnockOut-Serum
Replacement (Gibco), 0.1 mM 2-mercaptoethanol, 1% Pen/Strep
(Lonza), 1%non-essential amino acid solution, 2mML-glutamine,
8 ng/mL human FGF-2 (Miltenyi Biotec) or onMatrigel (BD Biosci-
ence) in StemMACS iPS-Brew XF (Miltenyi Biotec). hESCs (SA001
and H9) were cultivated on feeders as described above but in KO-
DMEM and DMEM/F12 (Gibco), respectively.
Cells were passaged with TrypLE or EDTA (Thermo Fisher Scien-
tific) every 4–7 days. Cells were replated at a density of 8,000–
12,500 cells/cm2 in medium supplemented with ROCK inhibitor
(Thiazovivin 2 mM; Miltenyi Biotec) for the first 48 hr. Afterward,
media change was conducted daily.
Differentiation of hiPSCs and hESCs
The mesDA-differentiation protocol was adapted from Kirkeby
et al. (2012b) with minor modifications as specified in Supple-
mental Experimental Procedures.
Dorsoventral patterning of neural progenitors (11 days) was per-
formed as described in Kirkeby et al. (2012b).
Immunomagnetic Cell Separation of Differentiated
Cells on d11 or d16
Differentiated cells were harvested with Accumax and separation
was performed using an indirect immunomagnetic labeling strat-
egy. In brief, for positive enrichment, 5 3 106 single cells were
stained in 0.1mL PEB buffer (PBS/2mMEDTA/0.5% BSA) with pri-
mary antibody (CD47-PE [Clone REA220], Miltenyi Biotec; titer
1:30) for 10 min at 4C. Cells were washed with 2 mL of medium,
centrifuged, and then incubated for 15 min at 4C in 0.1 mL of a
1:5 dilution of anti-PE-MicroBeads (Miltenyi Biotec) in medium.
Cells were washed with medium, centrifuged, and resuspended
in 0.5 mL of medium. To obtain the negative fraction, depletion
of IAP was performed using the same procedure but increasing
the titer of primary antibody to 1:10. In order to achieve higher
purity for enrichment of IAP+ cells, a second MS column was
used. After separation, cells were either investigated by flow cytom-
etry or seeded for further differentiation and immunofluorescence
analysis.
The antibody derived from the clone REA220 specifically
blocks binding of the widely used monoclonal antibody B6H12,
indicating that REA220 recognizes the same surface epitope as
the monoclonal antibody B6H12 (Figure S1).
Flow Cytometry
In order to distinguish different cell lines in one screening
approach, a CellTrace Violet Cell Proliferation Kit (Violet Dye,
Life Technologies) was used with a concentration of 2 mM accord-
ing to the manufacturer’s protocol.
For surface marker staining, primary antibody staining was per-
formed in PEB buffer for 10 min at 4C. After washing in PEB, sec-
ondary staining was performed for 10min at 4C. APC-conjugated
antibodies were used for the screening experiments (MACSMarker
Screen, human; prototypewith reduced set of surfacemarkers;Mil-
tenyi Biotec). Intracellular epitopes were stained using the FoxP3
Buffer Set (Miltenyi Biotec) after surface marker staining. In brief,1218 Stem Cell Reports j Vol. 9 j 1207–1220 j October 10, 2017cells were fixed for 30min at 4C. After the washing step, the intra-
cellular antibody was diluted in 13 Perm buffer and incubated for
30 min at 4C, washed, and resuspended in a suitable volume of
PEB buffer. Single cells were discriminated by FSC-A and FSC-H
properties. In the next gate, forward scatter (FSC) was applied
against the side scatter (SSC) to mark the population of interest.
Propidium iodide was used for discrimination of dead cells only
if cells were not permeabilized before. The gates for the fluores-
cence channel were set according to unstained and isotype con-
trols. Data were acquired using the MACSQuant Analyzer 10
and analyzed with the MACSQuantify Software (Miltenyi Biotec).
Antibodies used for flow cytometry and immunocytochemistry are
listed in Tables S1 and S2, respectively.
Microarray Analyses and qRT-PCR
Microarray and RT-PCR analysis were conducted following standard
procedures. The microarray data are available at NCBI GEO with
accession number GEO: GSE74991. For further details see Supple-
mentalExperimental Procedures.Differentiallyexpressedgenes (mi-
croarray analyses) are listed inTable S3. Primers are listed inTable S4.
Experimental Animal Studies
Adult female Sprague-Dawley rats (225–250 g; Charles River) were
housed in a 12-hr light/dark cycle with ad libitum access to food
and water. All experimental procedures were conducted following
the guidelines of the Ethical Committee for the use of Laboratory
Animals in Lund University. All procedures were conducted in
accordance with the European Union Directive (2010/63/EU)
and were approved by the Ethical Committee for the use of labora-
tory animals at Lund University and the Swedish Department of
Agriculture (Jordbruksverket). For further details, see Supplemental
Experimental Procedures.
Statistical Analysis
Statistical analysis was performed with GraphPad Prism6 unless
stated otherwise. All pooled data are presented as means ± SD. Sta-
tistical tests and the number of independent experiments relevant
for individual experiments are stated in the figures legends.
ACCESSION NUMBERS
The accession number for the gene expression datasets reported in
this paper is GEO: GSE74991.
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